A current perspective on the neuroprotective effects of nobiletin in neurodegenerative diseases

Öz

Abstract Nobiletin is a flavonoid compound with important biological activities found in the peel of citrus fruits such as lemon, orange and tangerine. Nobiletin is a compound that attracts a lot of attention due to its anticarcinogenic, anti-inflammatory, antiatherogenic, antiobesity and antidiabetic effects. In recent years, the potential effects of nobiletin on the central nervous system (CNS) have been investigated in detail and its role in neuronal disorders has been quite interesting. Results obtained from the studies carried out; nobiletin inhibits the expression of inflammatory factors in the nervous system, reduces the neurotoxic response, increases antioxidant capacity, inhibits cell death of neurons, promotes axon growth, reduces blood-brain barrier permeability, reduces brain edema, increases cAMP response element binding protein expression (CREB), improves memory. It has been shown that it has many biological functions such as healing and improving antioxidative stress capacity, preventing degeneration of the enteric nervous system, medulla spinalis and sciatic nerve. There is no definitive treatment for neurodegenerative diseases such as Alzheimer's and Parkinson's, which have become a global health problem by affecting a large number of individuals today. Although current treatments improve cognitive decline, they cannot prevent, stop, or reverse the disease's progression. Clinical studies have been and continue to be conducted to develop drugs that can cross the blood-brain barrier and have minimal or no side effects. The effects of Nobiletin, especially on the central nervous system (CNS), have the potential to support the treatment of many central nervous system diseases and cognitive disorders, especially neurodegenerative diseases such as Alzheimer's and Parkinson's, which are the most common in the world and whose prognosis cannot be completely changed with current treatment modalities. It can enable the development of effective treatment and protective modalities.

Anahtar Kelimeler

• Nobiletin
• Central Nervous System
• Neuroprotective
• Neurodegenerative

Nobiletin’in nörodejeneratif hastalıklarda nöroprotektif etkilerine ilişkin güncel bir bakış

Öz

Öz Nobiletin, limon, portakal ve mandalina gibi turunçgillerin kabuğunda bulunan önemli biyolojik aktivitelere sahip bir flavonoid bileşiğidir. Nobiletin, antikanserojen, antienflamatuar, antiaterojenik, antiobezite antidiyabetik etkilerinden dolayı oldukça ilgi gören bir bileşiktir. Son yıllarda, nobiletinin santral sinir sistemi (SSS) üzerindeki potansiyel etkileri detaylı bir şeklide araştırılmış ve nöronal bozukluklardaki rolü oldukça ilgi çekici olmuştur. Yapılan çalışmalardan elde edilen sonuçlar; nobiletinin sinir sisteminde inflamatuar faktörlerin ekspresyonunu inhibe etmek, nörotoksik yanıtı azaltmak, antioksidan kapasiteyi artırmak, nöronların hücre ölümünü engellemek, akson büyümesini teşvik etmek, kan-beyin bariyeri geçirgenliğini azaltmak, beyin ödemini azaltmak, cAMP yanıt elemanı bağlayıcı protein ekspresyonunu (CREB) artırmak, hafızayı iyileştirmek ve antioksidatif stres kapasitesini iyileştirmek, enterik sinir sistemi, medulla spinalis ve siyatik sinir dejenerasyonunu engellemek gibi birçok biyolojik işlevlere sahip olduğunu göstermiştir. Günümüzde oldukça fazla sayıda bireyi etkileyerek küresel bir sağlık sorunu haline gelen Alzheimer ve Parkinson gibi nörodejeneratif hastalıklarda kullanılan mevcut tedavi yöntemleri ile kesin bir tedavisi bulunmamaktadır. Mevcut tedaviler bilişsel gerilemeyi iyileştirseler de hastalığın ilerlemesini önleyememekte, durduramamakta veya hastalığın neden olduğu etkiyi tersine çevirememektedir. Kan-beyin bariyerini geçebilen ve minimal veya hiç yan etkisi olmayan ilaçlar geliştirmek için klinik çalışmalar yapılmakta ve yapılmaya devam etmektedir. Nobiletin'in özellikle santral sinir sistemi (SSS) üzerindeki etkileri, Dünya’da en sık görülen ve mevcut tedavi modaliteleri ile prognozu tamamen değiştirilemeyen Alzheimer, Parkinson gibi nörodejeneratif hastalıklar başta olmak üzere birçok merkezi sinir sistemi hastalıkları ve bilişsel bozukluklarda tedaviye destek olma potansiyeli ile daha etkili tedavi ve protektif modalitelerin geliştirilmesini sağlayabilir.

Anahtar Kelimeler

• Nobiletin
• Santral Sinir Sistemi
• Nöroprotektif
• Nörodejeneratif

Kaynakça

1. Adhikari-Devkota A, Kurauchi Y, Yamada T, Katsuki H, Watanabe T, Devkota HP. (2019). Anti-neuroinflammatory activities of extract and polymethoxyflavonoids from immature fruit peels of Citrus 'Hebesu'. J Food Biochem. 43(6):e12813. doi: 10.1111/jfbc.12813. PMID: 31353615.
2. Asakawa T, Hiza A, Nakayama M., Inai M, Oyama D, Koide H, Shimizu K, Wakimoto T, Harada N, Tsukada H, Oku N, Kan T. (2011). PET imaging of NOB based on a practical total synthesis. Chemical Communication. 47 (10), 2868-2870. doi: https://doi.org/10.1039/C0CC04936K.
3. Australia, D., Baker, S., & Banerjee, S. (2019). Alzheimer’s Disease International World Alzheimer Report 2019: Attitudes to Dementia. Alzheimer’s Disease International: London, UK.
4. Bi J, Zhang H, Lu J, Lei W. (2016). NOB ameliorates isoflurane-induced cognitive impairment via antioxidant, anti-inflammatory and anti-apoptotic effects in aging rats. Mol Med Rep.14(6):5408-5414. doi: 10.3892/mmr.2016.5919. Epub 2016 Nov 1. PMID: 27840933.
5. Cao H, Chen X, Jassbi AR, Xiao J. (2015). Microbial biotransformation of bioactive flavonoids. Biotechnol Adv. 33(1):214-223. doi: 10.1016/j.biotechadv.2014.10.012. PMID: 25447420.
6. Cui Y, Wu J, Jung SC, Park DB, Maeng YH, Hong JY, Kim SJ, Lee SR, Kim SJ, Kim SJ, Eun SY. (2010). Anti-neuroinflammatory activity of NOB on suppression of microglial activation. Biol Pharm Bull. 33(11):1814-21. doi: 10.1248/bpb.33.1814. PMID: 21048305.
7. He Q, Fang X, Zhu T, Han S, Zhu H, Li S. (2019). Differential Proteomics Based on TMT and PRM Reveal the Resistance Response of Bambusa pervariabilis × Dendrocalamopisis grandis Induced by AP-Toxin. Metabolites. 10;9(8):166. doi: 10.3390/metabo9080166. PMID: 31405188; PMCID: PMC6724075.
8. Huang H, Li L, Shi W, Liu H, Yang J, Yuan X, Wu L. (2016). The Multifunctional Effects of NOB and Its Metabolites In Vivo and In Vitro. Evid Based Complement Alternat Med. 2016:2918796. doi: 10.1155/2016/2918796. PMID: 27761146; PMCID: PMC5059563.

9. Ikeda A, Nemoto K, Yoshida C, Miyata S, Mori J, Soejima S, Yokosuka A, Mimaki Y, Ohizumi Y, Degawa M. (2013). Suppressive effect of NOB, a citrus polymethoxyflavonoid that downregulates thioredoxin-interacting protein expression, on tunicamycin-induced apoptosis in SK-N-SH human neuroblastoma cells. Neurosci Lett. 9;549:135-9. doi: 10.1016/j.neulet.2013.06.004. PMID: 23774476.
10. Jeong KH, Jeon MT, Kim HD, Jung UJ, Jang MC, Chu JW, Yang SJ, Choi IY, Choi MS, Kim SR. (2015). NOB protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease. J Med Food. 18(4):409-14. doi: 10.1089/jmf.2014.3241. PMID: 25325362.
11. Kim HG, Ju MS, Ha SK, Lee H, Lee H, Kim SY, Oh MS. (2012). Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol Pharm Bull. 35(8):1287-94. doi: 10.1248/bpb.b12-00127. PMID: 22863927.
12. Kim, E., Nohara, K., Wirianto, M., Escobedo Jr, G., Lim, J. Y., Morales, R.,Yoo, SH, Chen, Z. (2021). Effects of the clock modulator NOB on circadian rhythms and pathophysiology in female mice of an Alzheimer’s disease model. Biomolecules. 11(7):1004. doi: 10.3390/biom11071004. PMID: 34356628; PMCID: PMC8301787.
13. Lan HC, Li SZ, Li K, Liu EH. (2021). In vitro human intestinal microbiota biotransformation of NOB using liquid chromatography-mass spectrometry analysis and background subtraction strategy. J Sep Sci. 44(10):2046-2053. doi: 10.1002/jssc.202001150. PMID: 33682313.
14. Lee E, Park HR, Ji ST, Lee Y, Lee J. (2014). Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. J Neurosci Res. 92(1):130-9. doi: 10.1002/jnr.23307. PMID: 24166733.
15. Matsuzaki K, Miyazaki K, Sakai S, Yawo H, Nakata N, Moriguchi S, Fukunaga K, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y. (2008). NOB, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus. Eur J Pharmacol. 14;578(2-3):194-200. doi: 10.1016/j.ejphar.2007.09.028. PMID: 17976577.
16. Matsuzaki K, Yamakuni T, Hashimoto M, Haque AM, Shido O, Mimaki Y, Sashida Y, Ohizumi Y. (2006). NOB restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci Lett. 12;400(3):230-4. doi: 10.1016/j.neulet.2006.02.077. PMID: 16581185.
17. Matsuzaki K, Ohizumi Y. (2021). Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders. Nutrients. 4;13(1):145. doi: 10.3390/nu13010145. PMID: 33406641; PMCID: PMC7824236.
18. Murata T, Ishiwa S, Lin X, Nakazawa Y, Tago K, Funakoshi-Tago M. (2023). The citrus flavonoid, nobiletin inhibits neuronal inflammation by preventing the activation of NF-κB. Neurochem Int. 171:105613. doi: 10.1016/j.neuint.2023.105613. Epub 2023 Sep 27. PMID: 37774798.
19. Nagase H, Omae N, Omori A, Nakagawasai O, Tadano T, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y. (2005 a). NOB and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun. 2;337(4):1330-6. doi: 10.1016/j.bbrc.2005.10.001. PMID: 16253614.3.
20. Nagase H, Yamakuni T, Matsuzaki K, Maruyama Y, Kasahara J, Hinohara Y, Kondo S, Mimaki Y, Sashida Y, Tank AW, Fukunaga K, Ohizumi Y. (2005 (b)) Mechanism of neurotrophic action of NOB in PC12D cells. Biochemistry. 25;44(42):13683-91. doi: 10.1021/bi050643x. PMID: 16229458.
21. Nakajima A, Aoyama Y, Nguyen TT, Shin EJ, Kim HC, Yamada S, Nakai T, Nagai T, Yokosuka A, Mimaki Y, Ohizumi Y, Yamada K. (2013). NOB, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse. Behav Brain Res. 1;250:351-60. doi:10.1016/j.bbr.2013.05.025. PMID: 23714077.
22. Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, Yokosuka A, Mimaki Y, Yokoi T, Ohizumi Y, Yamada K. (2015). NOB, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behav Brain Res. 1;289:69-77. doi: 10.1016/j.bbr.2015.04.028. PMID: 25913833.
23. Nakajima A, Yamakuni T, Matsuzaki K, Nakata N, Onozuka H, Yokosuka A, Sashida Y, Mimaki Y, Ohizumi Y. (2007). NOB, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling. J Pharmacol Exp Ther. 321(2):784-90. doi: 10.1124/jpet.106.117010. PMID: 17289833.
24. Nakajima M, Shimizu R, Furuta K, Sugino M, Watanabe T, Aoki R, Okuyama S, Furukawa Y. (2016). Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination. Brain Res. 15;1639:28-37. doi: 10.1016/j.brainres.2016.02.041. PMID: 26944297.
25. Nichols MR, St-Pierre MK, Wendeln AC, Makoni NJ, Gouwens LK, Garrad EC, Sohrabi M, Neher JJ, Tremblay ME, Combs CK. (2019). Inflammatory mechanisms in neurodegeneration. J Neurochem. 149(5):562-581. doi: 10.1111/jnc.14674. PMID: 30702751; PMCID: PMC6541515.
26. Ohizumi Y (2015). [A new strategy for preventive and functional therapeutic methods for dementia--approach using natural products]. Yakugaku Zasshi, 135(3):449-64. Japanese. doi: 10.1248/yakushi.14-00245. PMID: 25759053.
27. Olofinsan KA, Salau VF, Erukainure OL, Islam MS. (2022). Harpephyllum caffrum fruit (wild plum) facilitates glucose uptake and modulates metabolic activities linked to neurodegeneration in isolated rat brain: An in vitro and in silico approach. J Food Biochem. 46(8): e14177. doi: 10.1111/jfbc.14177. PMID: 35396859.
28. Onozuka H, Nakajima A, Matsuzaki K, Shin RW, Ogino K, Saigusa D, Tetsu N, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y. (2008). NOB, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 326(3):739-44. doi: 10.1124/jpet.108.140293. PMID: 18544674.
29. Pang, Y., Xiong, J., Wu, S., Ding, W. (2023). A review on recent advances on NOB in central and peripheral nervous system diseases. European Journal of Medical Research. 28(1), 485.doi: https://doi.org/10.1186/s40001-023-01450-7.
30. Pardridge WM. (2009). Alzheimer's disease drug development and the problem of the blood-brain barrier. Alzheimers Dement. 5(5):427-32. doi: 10.1016/j.jalz.2009.06.003. PMID: 19751922; PMCID: PMC2756824.
31. Robinson L, Tang E, Taylor JP (2015). Dementia: timely diagnosis and early intervention. BMJ. 16;350:h3029. doi: 10.1136/bmj.h3029. PMID: 26079686; PMCID: PMC4468575.
32. Saigusa D, Shibuya M, Jinno D, Yamakoshi H, Iwabuchi Y, Yokosuka A, Mimaki Y, Naganuma A, Ohizumi Y, Tomioka Y, Yamakuni T. (2011). High-performance liquid chromatography with photodiode array detection for determination of NOB content in the brain and serum of mice administrated the natural compound. Anal Bioanal Chem. 400(10):3635-41. doi: 10.1007/s00216-011-5031-2. Epub 2011 May 11. PMID: 21559759.
33. Sarkar, S.; Raymick, J.; Imam, S. (2016). Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives. Int. J. Mol. Sci. 8;17(6):904. doi: 10.3390/ijms17060904. PMID: 27338353; PMCID: PMC4926438.
34. Shi, M.; Guo, Q.; Xiao, Z.; Sarengaowa; Xiao, Y.; Feng, K. (2024). Recent Advances in the Health Benefits and Application of Tangerine Peel (Citri Reticulatae Pericarpium): A Review. Foods. 13 (13) : 1978. https://doi.org/ 10.3390/foods13131978.
35. Shimazu, R., Anada, M., Miyaguchi, A., Nomi, Y., Matsumoto, H. (2021). Evaluation of blood–brain barrier permeability of polyphenols, anthocyanins, and their metabolites. Journal of Agricultural and Food Chemistry. 6;69(39):11676-11686. doi: 10.1021/acs.jafc.1c02898. PMID: 34555897.
36. Singh SP, Wahajuddin, Tewari D, Patel K, Jain GK. (2011). Permeability determination and pharmacokinetic study of NOB in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia. 82(8):1206-14. doi:10.1016/j.fitote.2011.08.010. PMID: 21888953.
37. Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. (2019). Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease. Int J Mol Sci. 8;20(3):719. doi: 10.3390/ijms20030719. PMID: 30743990; PMCID: PMC6386829.
38. Wang CC, Kong JY, Xue CH, Zhang TT, Wang YM. (2023). Antarctic Krill Oil Exhibited Synergistic Effects with NOB and Theanine on Regulating Ligand-Specific Receptor-Mediated Transcytosis in Blood-Brain Barrier by Inhibiting Alkaline Phosphatase in SAMP8 Mice. Mol Nutr Food Res. 67(8):e2200825. doi: 10.1002/mnfr.202200825. PMID: 36815232.
39. WHO (2019). Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. Geneva: World Health Organization. PMID: 31219687.
40. Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K. (2014). NOB treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience. 14;259:126-41. doi: 10.1016/j.neuroscience.2013.11.051. PMID: 24316474.
41. Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K. (2009). NOB improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. 27;1295:218-29. doi: 10.1016/j.brainres.2009.07.081. PMID: 19646972.
42. Yasuda N, Ishii T, Oyama D, Fukuta T, Agato Y, Sato A, Shimizu K, Asai T, Asakawa T, Kan T, Yamada S, Ohizumi Y, Oku N. (2014). Neuroprotective effect of NOB on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats. Brain Res. 22;1559:46-54. doi: 10.1016/j.brainres.2014.02.007. PMID: 24534366.
43. Youn K, Lee S, Jun M. (2019). Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity. Nutrients. 4;11(11):2648. doi: 10.3390/nu11112648. PMID: 31689949; PMCID: PMC6893598.
44. Zhang L, Zhang X, Zhang C, Bai X, Zhang J, Zhao X, Chen L, Wang L, Zhu C, Cui L, Chen R, Zhao T, Zhao Y. (2016). NOB promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo. Brain Res. 1;1636:130-141. doi: 10.1016/j.brainres.2016.02.013. PMID: 26874072.
45. Zhang L, Zhao H, Zhang X, Chen L, Zhao X, Bai X, Zhang J. (2013). NOB protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res Bull. 96:45-53. doi: 10.1016/j.brainresbull.2013.04.009. PMID: 23644141.
46. Zhang M, Zhang X, Zhu J, Zhao DG, Ma YY, Li D, Ho CT, Huang Q. (2021). Bidirectional interaction of NOB and gut microbiota in mice fed with a high-fat diet. Food Funct. 26;12(8):3516-3526. doi: 10.1039/d1fo00126d. PMID: 33900329.